AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Cboe Global Markets
CBOE
|
+$1.01B |
| 2 |
Applovin
APP
|
+$582M |
| 3 |
Broadcom
AVGO
|
+$564M |
| 4 |
Astera Labs
ALAB
|
+$498M |
| 5 |
Axon Enterprise
AXON
|
+$483M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.39B |
| 2 |
Walt Disney
DIS
|
+$843M |
| 3 |
Idexx Laboratories
IDXX
|
+$653M |
| 4 |
Microsoft
MSFT
|
+$609M |
| 5 |
Arista Networks
ANET
|
+$596M |
Sector Composition
| 1 | Technology | 29.03% |
| 2 | Healthcare | 12.31% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Financials | 11.01% |
| 5 | Communication Services | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Tejon Ranch
TRC
$447M
| $253K | ﹤0.01% |
15,922
| – | – |
|
2952
Preformed Line Products
PLPC
$949M
| $253K | ﹤0.01% |
1,980
-90
| -4% | -$11.5K |
|
2953
Pulse Biosciences
PLSE
$1.01B
| $252K | ﹤0.01% |
14,500
| – | – |
|
2954
Redwire
RDW
$1.18B
| $251K | ﹤0.01% |
15,270
-20,920
| -58% | -$344K |
|
2955
VanEck Steel ETF
SLX
$81.7M
| $251K | ﹤0.01% |
+4,288
| New | +$251K |
|
|
GRAL
2956
GRAIL, Inc. Common Stock
GRAL
$1.32B
| $250K | ﹤0.01% |
13,992
-177
| -1% | -$3.16K |
|
|
ITOS
2957
DELISTED
iTeos Therapeutics
ITOS
| $250K | ﹤0.01% |
32,510
| – | – |
|
2958
Manitowoc
MTW
$356M
| $250K | ﹤0.01% |
27,335
-4,195
| -13% | -$38.3K |
|
2959
iShares MSCI EAFE Small-Cap ETF
SCZ
$10.8B
| $249K | ﹤0.01% |
4,100
| – | – |
|
2960
Vanguard Consumer Discretionary ETF
VCR
$6.47B
| $248K | ﹤0.01% |
661
| – | – |
|
|
NXDR
2961
Nextdoor Holdings
NXDR
$767M
| $248K | ﹤0.01% |
104,580
| – | – |
|
2962
NVE Corp
NVEC
$317M
| $246K | ﹤0.01% |
3,020
-170
| -5% | -$13.8K |
|
2963
Jakks Pacific
JAKK
$194M
| $246K | ﹤0.01% |
8,730
| – | – |
|
2964
Biomea Fusion
BMEA
$109M
| $246K | ﹤0.01% |
63,300
-6,930
| -10% | -$26.9K |
|
2965
Lufax Holding
LU
$2.6B
| $245K | ﹤0.01% |
102,530
| – | – |
|
2966
Tyra Biosciences
TYRA
$653M
| $244K | ﹤0.01% |
17,570
| – | – |
|
2967
Sandstorm Gold
SAND
$3.39B
| $244K | ﹤0.01% |
43,712
| – | – |
|
2968
Monte Rosa Therapeutics
GLUE
$303M
| $244K | ﹤0.01% |
35,140
| – | – |
|
2969
Viant Technology
DSP
$164M
| $243K | ﹤0.01% |
12,810
| – | – |
|
2970
The Beauty Health Co
SKIN
$282M
| $242K | ﹤0.01% |
152,380
| – | – |
|
2971
LendingTree
TREE
$970M
| $242K | ﹤0.01% |
6,250
-4,880
| -44% | -$189K |
|
2972
Sana Biotechnology
SANA
$749M
| $242K | ﹤0.01% |
148,385
-21,690
| -13% | -$35.4K |
|
2973
Fate Therapeutics
FATE
$118M
| $242K | ﹤0.01% |
146,580
| – | – |
|
2974
Frontier Group Holdings
ULCC
$1.18B
| $242K | ﹤0.01% |
33,980
-60,350
| -64% | -$429K |
|
2975
SES AI
SES
$424M
| $240K | ﹤0.01% |
109,720
| – | – |
|